| Room #113 | Room #114 | ||||
---|---|---|---|---|---|---|
Phase | Population | Age | # of individuals | Genotype frequency | # of individuals | Genotype frequency |
START | MC | Adult | 27 (14/13) | 56.3% | 31 (14/17) | 55.8% |
Young | 22 (0/0/22) | 12 (7/5) | ||||
CB | Adult | 23 (10/13) | 43.7% | 26 (11/15) | 44.2% | |
Young | 15 (1/10/4) | 18 (13/5) | ||||
HEALTH CHECK | MC | Adult | 34 (18/16) | 37% | 42 (16/26) | 37.2% |
Young | Â | Â | ||||
CB | Adult | 35 (16/19) | 38.0% | 45 (20/25) | 40% | |
Young | Â | Â | ||||
N/A | Adult | – | 25% | – | 23.0% | |
Young | 23 (8/12/3) | 26 (11/15) | ||||
END | MC | Adult | 30 (16/14) | 51.7% | 40 (15/25) | 24.0% |
Young | 45 (20/25) | 8 (3/4/1) | ||||
CB | Adult | 34 (15/19) | 33.8% | 42 (20/22) | 47.0% | |
Young | 15 (8/7) | 52 (26/26) | ||||
MIX | Adult | – | 13.1% | – | 23.0% | |
Young | 19 (11/8) | 46 (13/22/11) | ||||
N/A | Adult | – | 1.4% | – | 6.0% | |
Young | 2 (1/1) | 12 (4/5/3) |